US Stock MarketDetailed Quotes

BIAF bioAffinity Technologies

Watchlist

0.946
+0.056+6.30%

Trading Dec 30 11:46 ET

14.74MMarket Cap-1.18P/E (TTM)

bioAffinity Technologies Stock Forum

ahhh_shicha__yabicha

Dec 19 04:33

$bioAffinity Technologies (BIAF.US)$ This company was also advertising on CNBC earlier this year when I bought in. Why the investor webinar far between earnings reports? Something is up. They need to get SG&A under control. I'm looking for a partnership with a major pharmaceutical to assist with the CyPath rollout. Less expensive to train the trainers.

Stock_Drift

Dec 17 07:16

$bioAffinity Technologies (BIAF.US)$ $BIOAFFINITY TECHNOLOGIES INC C/WTS 12/08/2027 (TO PUR COM) (BIAFW.US)$

Join bioAffinity Technologies’ Exclusive Live Investor Webinar and Q&A Session on Thursday, December 19

10baggerbamm

Dec 17 06:00

$bioAffinity Technologies (BIAF.US)$ this company just started advertising this morning on CNBC with a 30 second commercial to pump up the stock price. it seems every week there's another company added to CNBC to try to jump start their stock prices and sometimes it works sometimes it works in a very big way and sometimes nothing happens... nevertheless the company is spending money to try to pump up the stock

Stock_Drift

Oct 21 10:48

$bioAffinity Technologies (BIAF.US)$

Jaguar8

Oct 18 13:58

NEWS

$bioAffinity Technologies (BIAF.US)$
WallachBeth Capital Announces Pricing of bioAffinity Technologies $2.66 Million Registered Direct Offering & Concurrent Private Placement

Stock_Drift

Oct 18 12:28

$bioAffinity Technologies (BIAF.US)$

Teddy123

Oct 9 07:29

bioAffinity Technologies Awarded U.S. Federal Supply Schedule Contract for CyPath® Lung Test

$bioAffinity Technologies (BIAF.US)$
SAN ANTONIO--(BUSINESS WIRE)-- bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company focused on the need for noninvasive tests for the detection of early-stage cancer, today announced that CyPath® Lung, its noninvasive test to detect early-stage lung cancer, will be added to the U.S. Federal Supply Schedule, a procurement system that provides the...

zezzzo

Jul 18 09:34

$bioAffinity Technologies (BIAF.US)$ news

Stock Region

Mar 5 20:09

Medical Technology Company Reports Major Revenue Growth

bioAffinity Technologies: Accelerating the Future of Lung Cancer Detection with CyPath® Lung.
bioAffinity Technologies, a leading player in the field of early cancer detection, recently reported an acceleration in sales growth of its revolutionary product, CyPath® Lung. This surge signifies a growing demand for innovative, non-invasive methods for early lung cancer detection and highlights the potential of CyPath® Lung to revolutionize the i...